Use of bevacizumab (Bev) in real life for first-line (fl) treatment of ovarian cancer (OC). Part1: the ENCOURAGE cohort of 1158 patients (pts) by GINECO
Berton-Rigaud, D., Selle, F., Floquet, A., Mollon, D., Lescaut, W., Kaminsky, M-C., Ray-Coquard, I.L., Largillier, R., Savoye, A-M., Barletta, H., Pautier, P., Orfeuvre, H., Baron, M., Marti, A., MouyVolume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw374.42
Date:
October, 2016
File:
PDF, 39 KB
english, 2016